Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
10.60
-0.05 (-0.47%)
Feb 27, 2026, 4:00 PM EST - Market closed
DAWN Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for DAWN stock have an average target of 27.11, with a low estimate of 17 and a high estimate of 36. The average target predicts an increase of 155.75% from the current stock price of 10.60.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DAWN stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $29 → $30 | Buy | Maintains | $29 → $30 | +183.02% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $22 | Strong Buy | Maintains | $25 → $22 | +107.55% | Feb 25, 2026 |
| Needham | Needham | Strong Buy Maintains $18 → $17 | Strong Buy | Maintains | $18 → $17 | +60.38% | Feb 25, 2026 |
| TD Cowen | TD Cowen | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +220.75% | Jan 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +135.85% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
233.28M
from 158.18M
Increased by 47.48%
Revenue Next Year
305.82M
from 233.28M
Increased by 31.10%
EPS This Year
-0.66
from -1.04
EPS Next Year
0.01
from -0.66
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 283.3M | 389.8M | |||
| Avg | 233.3M | 305.8M | |||
| Low | 182.3M | 240.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 79.1% | 67.1% | |||
| Avg | 47.5% | 31.1% | |||
| Low | 15.2% | 2.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.07 | 0.56 | |||
| Avg | -0.66 | 0.01 | |||
| Low | -1.79 | -0.30 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.